Novo Holdings Blueprint Medicines Corp Transaction History

Novo Holdings

$1.23 Billion
Q4 2024

A detailed history of Novo Holdings transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Novo Holdings holds 175,000 shares of BPMC stock, worth $14.8 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares

175,000

Previous 175,000 -0.0%

Holding current value

$14.8 Million

Previous $16.2 Million 5.67%

% of portfolio

1.24%

Previous 1.13%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $15.6 Million - $20 Million	-183,626 Reduced 51.2%	175,000 $18.9 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $36,585 - $49,895	-500 Reduced 0.14%	358,626 $34 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $7.29 Million - $15.4 Million	-165,874 Reduced 31.6%	359,126 $33.1 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $3.57 Million - $5.03 Million	76,196 Added 16.98%	525,000 $26.4 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $2.99 Million - $3.94 Million	78,804 Added 21.3%	448,804 $20.2 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $2.19 Million - $3.55 Million	53,326 Added 16.84%	370,000 $16.2 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $4.03 Million - $6.25 Million	89,148 Added 39.18%	316,674 $16 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $1.65 Million - $3.36 Million	30,526 Added 15.5%	227,526 $14.5 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $3.5 Million - $4.73 Million	-37,979 Reduced 16.16%	197,000 $22.1 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $1.45 Million - $2.02 Million	-21,788 Reduced 8.49%	234,979 $21.8 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $1.28 Million - $1.78 Million	22,500 Added 9.6%	256,767 $20 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $3.06 Million - $5.23 Million	63,600 Added 37.27%	234,267 $13.7 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $2.75 Million - $3.82 Million	37,691 Added 28.34%	170,667 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $4.81 Million - $6.4 Million	65,409 Added 96.81%	132,976 $12.5 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $3.29 Million - $5.85 Million	67,567 New	67,567 $5.41 Million

Others Institutions Holding BPMC

# of Institutions

382

Shares Held

61.5M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.06B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.

Account